Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% |
|
-.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.34T | |
+18.43% | 12TCr | |
+19.81% | 11TCr | |
-23.74% | 1.93TCr | |
-18.45% | 1.62TCr | |
-19.97% | 1.56TCr | |
-49.33% | 1.46TCr | |
+57.08% | 1.43TCr | |
+7.95% | 1.4TCr | |
+126.04% | 1.13TCr |
- Stock Market
- Equities
- PZRXQ Stock
- News PhaseRx, Inc.
- PhaseRx, Inc. Appoints Robert W. Overell as Principal Accounting Officer